Eventide Asset Management - INTERCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Eventide Asset Management ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$829,000820,0000.02%
Other shareholders

There were no reported owners of INTERCEPT PHARMACEUTICALS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders